Halbert Hargrove Global Advisors’s Boston Scientific BSX Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-23	Closed	-$977	–	398
2026 Q2	$977	Buy	+23	New	+$1.25K	﹤0.01%	445
2025 Q4	–	Sell	-115	Closed	-$11.2K	–	413
2025 Q3	$11.2K	Buy	+115	New	+$11.9K	﹤0.01%	312
2025 Q2	–	Sell	-18	Closed	-$1.82K	–	358
2025 Q1	$1.82K	Buy	+18	New	+$1.81K	﹤0.01%	409

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Halbert Hargrove Global Advisors's BSX Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 23 shares — an estimated $977 sold.

Halbert Hargrove Global Advisors first reported a position in BSX in Q1 2025 and held it in 3 quarters. The position peaked at $11.2K in Q3 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Halbert Hargrove Global Advisors reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
Halbert Hargrove Global Advisors sold 23 Boston Scientific shares in Q3 2026, an estimated $977.
Halbert Hargrove Global Advisors first reported a position in Boston Scientific in Q1 2025 and held it in 3 quarters.
Halbert Hargrove Global Advisors's Boston Scientific position peaked at $11.2K in Q3 2025.
534 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.